Shares of PetMed Express Inc. (NASDAQ:PETS) saw an uptick in trading volume on Thursday . 267,907 shares were traded during trading, an increase of 47% from the previous session’s volume of 182,398 shares.The stock last traded at $19.52 and had previously closed at $19.38.

Several brokerages recently weighed in on PETS. Zacks Investment Research raised PetMed Express from a “hold” rating to a “strong-buy” rating and set a $22.00 target price for the company in a research note on Wednesday, May 11th. Craig Hallum raised PetMed Express from a “sell” rating to a “hold” rating in a research note on Monday, May 9th.

The company’s 50 day moving average is $18.76 and its 200 day moving average is $17.86. The company has a market capitalization of $391.71 million and a price-to-earnings ratio of 19.03.

PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, May 9th. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.25 by $0.02. During the same period last year, the business posted $0.25 earnings per share. The firm earned $55.40 million during the quarter, compared to analyst estimates of $50.20 million. The firm’s quarterly revenue was up 10.8% on a year-over-year basis. On average, analysts anticipate that PetMed Express Inc. will post $1.06 EPS for the current year.

In other news, CFO Bruce S. Rosenbloom sold 5,500 shares of PetMed Express stock in a transaction on Monday, May 9th. The stock was sold at an average price of $19.54, for a total value of $107,470.00. Following the completion of the sale, the chief financial officer now directly owns 44,767 shares of the company’s stock, valued at approximately $874,747.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Several large investors recently made changes to their positions in PETS. GSA Capital Partners LLP boosted its stake in shares of PetMed Express by 38.0% in the fourth quarter. GSA Capital Partners LLP now owns 113,673 shares of the company’s stock worth $1,948,000 after buying an additional 31,274 shares during the period. WBI Investments Inc. boosted its stake in shares of PetMed Express by 6.8% in the fourth quarter. WBI Investments Inc. now owns 100,469 shares of the company’s stock worth $1,722,000 after buying an additional 6,425 shares during the period. Afam Capital Inc. boosted its stake in shares of PetMed Express by 1.6% in the fourth quarter. Afam Capital Inc. now owns 145,512 shares of the company’s stock worth $2,494,000 after buying an additional 2,224 shares during the period. Finally, Rhumbline Advisers boosted its stake in shares of PetMed Express by 3.0% in the fourth quarter. Rhumbline Advisers now owns 67,377 shares of the company’s stock worth $1,155,000 after buying an additional 1,940 shares during the period.

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds is a pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs and cats, direct to the consumer. The Company offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.